REJUVANAD+ PRO

Rejuva NAD+ Pro is a sterile intravenous formulation containing 500 mg of nicotinamide adenine dinucleotide (NAD+) per vial. Manufactured by PENMIX Ltd. in South Korea, it is presented as a 4th-generation NAD+ therapy intended for administration by licensed healthcare professionals in clinical IV therapy settings. NAD+ is a naturally occurring coenzyme involved in cellular energy metabolism and NAD-dependent processes such as DNA repair and signaling. Practices interested in Rejuva NAD+ Pro can contact the Doctor Medica support team for guidance on availability and professional sourcing.

Product Specifications

• Active Compound: Nicotinamide Adenine Dinucleotide (NAD+)
• Strength: 500 mg per vial
• Form: Sterile intravenous IV infusion solution
• Manufacturer: PENMIX Ltd.
• Country of Origin: South Korea
• Brand: Rejuva NAD+
• Product Generation: 4th generation NAD+ therapy
• Storage Requirement: Temperature-controlled refrigeration at 2–8°C
• Delivery: Cold chain required
• Package Content: 1 vial (Rejuvanad 500mg single box)
• Dimensions: Width: 30 mm | Height: 64 mm | Length: 36 mm

What Is Rejuva NAD+ Pro 500mg?

Rejuva NAD+ Pro 500mg vial is a sterile formulation of nicotinamide adenine dinucleotide developed for intravenous administration in professional clinical settings. Each vial contains 500 mg of NAD+ and requires preparation according to the manufacturer’s instructions before administration. The product is intended for use by professionals working in IV therapy and injection therapy environments.

NAD+ is found naturally in living cells and participates in numerous biochemical reactions. One of its best-established roles is as an electron carrier in oxidation-reduction reactions. Through the NAD+/NADH redox pair, it contributes to glycolysis, the citric acid cycle, and mitochondrial respiration, all of which support cellular ATP production.[1]

The Rejuva NAD+ Pro 500mg vial requires refrigerated storage at 2°C to 8°C. Cold-chain conditions should be maintained during storage, handling, and transportation in accordance with the product documentation.

For practices evaluating how to buy RejuvaNAD+, product authenticity, professional-use requirements, storage conditions, and temperature-controlled delivery should be reviewed before sourcing. The Doctor Medica support team can provide information on availability and appropriate professional ordering channels.

Mechanism of Action and the Role of NAD+

The role of NAD begins with its ability to alternate between two chemical states: oxidized NAD+ and reduced NADH. This reversible conversion allows NAD to accept and donate electrons during metabolic reactions, which is fundamental to how cells generate usable energy.

Within mitochondria, NADH transfers electrons generated through nutrient metabolism into the electron transport chain. This process contributes to the proton gradient that drives the production of adenosine triphosphate (ATP), which cells rely on as a primary source of usable energy.[1]

NAD+ and DNA Repair

Another established role in DNA repair involves PARP enzymes. When certain forms of DNA damage occur, PARPs use NAD+ as a substrate to generate ADP-ribose polymers that recruit and regulate DNA repair machinery.[2]

NAD+ is also consumed by sirtuins, a family of NAD-dependent enzymes involved in metabolic regulation, chromatin activity, and cellular signaling. Because these pathways draw on the same intracellular NAD+ pool, NAD availability is closely integrated with metabolism and cellular maintenance.[2]

Research has demonstrated that NAD+ concentrations can change with age and disease states. Maintaining NAD levels for optimal cellular function has become a focus of ongoing investigation, but the biological observation that levels decline in some tissues should not be interpreted as evidence that intravenous NAD+ reverses aging or improves specific health outcomes. Human evidence for these applications remains limited.[3]

Rejuva NAD+ Pro Indications and Clinical Applications

Rejuva NAD+ Pro is positioned for professional NAD IV therapy and injection therapy settings where administration is determined by a licensed healthcare practitioner. The product has also been marketed as a 4th gen NAD skin booster in some contexts, though its primary positioning is as a sterile intravenous IV infusion solution for systemic NAD+ repletion rather than topical or dermal application.

The biochemical rationale for NAD+ therapy is based primarily on the molecule’s established participation in cellular energy metabolism, mitochondrial redox reactions, DNA repair pathways, and NAD-dependent signaling.

A 2026 systematic review examining NAD-related interventions found that evidence in humans is considerably stronger for oral NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide than for direct parenteral NAD+. The review identified no eligible clinical outcome trials evaluating IV or intramuscular NAD+ itself for anti-aging or wellness indications.[3] For practitioners interpreting the available evidence, this distinction matters: the preclinical rationale for NAD+ repletion is well established, but extrapolating from oral precursor data to direct IV administration involves assumptions that have not yet been validated in controlled human trials.

Practices researching how to buy NAD+ therapy wholesale should distinguish between the biological role of NAD+ and claims made about particular therapeutic outcomes. Product selection should be based on clinical appropriateness, professional-use requirements, storage integrity, and applicable local regulations.

Administration and IV Therapy Protocol

Rejuva NAD+ Pro is intended for intravenous administration by licensed healthcare professionals in an appropriate clinical setting. Because body chemistry varies effectiveness and tolerance can differ between patients; administration should follow the manufacturer’s instructions and be supported by appropriate assessment and monitoring.

• Preparation: The ingredient, once reconstituted, should be prepared according to the manufacturer’s instructions before administration.
• Dilution and infusion rate: The treating professional should determine the appropriate dilution and infusion rate based on product documentation, patient assessment, and applicable standards of practice.
• IV administration: Administer through established intravenous access in a setting where the patient can be monitored throughout the infusion.
• Treatment frequency: The frequency and overall treatment protocol should be determined by the clinician rather than applied as a fixed schedule across all patients.
• Patient monitoring: Individual tolerance may differ, and reactions may also differ based on the infusion protocol itself and each patient’s health status. Reported infusion-related symptoms with IV NAD+ have included gastrointestinal discomfort, increased heart rate, and chest pressure in some recipients.[4]
• Clinical considerations: Medical history, concurrent medications, and underlying conditions may all influence how a patient responds.

These considerations make administration just as important as the product selected. When buying IV therapy products for professional use, practices should consider handling requirements, traceable sourcing, storage conditions, and the clinical protocols needed to support safe administration, rather than comparing products on vial strength alone.

Storage and Cold Chain Requirements

Rejuva NAD+ Pro requires temperature-controlled storage. Practitioners should store in the refrigerator at a temperature between 2–8°C, with cold-chain conditions maintained during transportation and storage.

Cold-chain integrity should extend from shipment through receipt and storage at the clinic. On arrival, healthcare facilities should verify that the product has been transported appropriately and store it promptly according to the manufacturer’s specifications. Shipping conditions matter for this product class, since temperature excursions during transit can compromise the stability of NAD+ formulations.

Practices that check for wholesale buying options should be aware that larger inventory volumes require adequate refrigerated storage capacity and consistent temperature monitoring. Ordering quantities should reflect the clinic’s expected use and its ability to maintain the required temperature range throughout the product’s storage period, and shipping arrangements should be confirmed with the supplier ahead of delivery.

Safety and Considerations

The FDA has raised concerns regarding certain compounded NAD+ injectable products. In 2024, the agency warned compounders not to use food-grade NAD+ ingredients in sterile injectable preparations because such ingredients may not be suitable for sterile drug compounding. The FDA reported adverse events including severe chills, shaking, vomiting, and fatigue associated with some compounded injectable NAD+ products.[5]

These FDA concerns relate specifically to compounding practices and should not be interpreted as establishing the regulatory status of Rejuva NAD+ Pro itself. They do, however, highlight the importance of pharmaceutical-grade ingredients, appropriate sterile manufacturing practices, traceability, and careful sourcing for any injectable NAD+ product. Clinics evaluating where to buy Rejuva NAD+ Pro online should accordingly prioritize verified sourcing, product documentation, and cold-chain compliance over price alone.

Pregnant or breastfeeding women and individuals for whom safety information is insufficient should undergo appropriate professional assessment before treatment. Any suspected hypersensitivity or significant adverse reaction requires prompt clinical evaluation. The requirements to purchase Rejuva NAD+ Pro online differ by jurisdiction, and licensed professionals should verify that their regional regulatory framework permits its use before ordering.

Legal Status and Regulatory Information

The regulatory status of injectable NAD+ products, including RejuvaNAD+ Pro, varies by jurisdiction. Healthcare providers should verify the local requirements governing the importation, prescribing, storage, and administration of this product before use.

NAD+ is naturally present in the body, but this does not mean that intravenous NAD+ is approved for every marketed indication. As noted above, the FDA has also raised concerns about certain compounded NAD+ injectable preparations, which underscores the importance of distinguishing between manufactured pharmaceutical products and compounded formulations when assessing regulatory risk.[5]

Clinics interested in RejuvaNAD+ Pro can contact Doctor Medica for guidance on product information, documentation, and professional sourcing.

Citations

[1] Griffiths, Hollie B S et al. “Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.” Biochemical Society transactions vol. 48,3 (2020): 733-744. doi:10.1042/BST20190033

[2] Strømland, Øyvind et al. “The balance between NAD⁺ biosynthesis and consumption in ageing.” Mechanisms of ageing and development vol. 199 (2021): 111569. doi:10.1016/j.mad.2021.111569

[3] Gallagher, Cory, and Owoturo Oluwaseun Emmanuel. “NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.” Ageing research reviews vol. 116 (2026): 103057. doi:10.1016/j.arr.2026.103057

[4] Reyna, Kirsten et al. “Intravenous infusion of nicotinamide adenine dinucleotide (NAD⁺) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting.” Frontiers in aging vol. 7 1652582. 2 Feb. 2026, doi:10.3389/fragi.2026.1652582

[5] U.S. Food and Drug Administration. “FDA Reminds Compounders to Use Ingredients Suitable for Sterile Compounding.” U.S. Food and Drug Administration, 30 Oct. 2024, www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-use-ingredients-suitable-sterile-compounding.

For licensed healthcare professionals only. This content is for informational purposes only and does not constitute medical advice. Cold chain integrity is essential.